People need to understand the entitlement offer that occurred in April 2022 to understand the repricing aspect of this entitlement offer.
In 2022 Viburnum agreed to fully underwrite an entitlement offer at $0.77 and then UBI shares fell below the offer price. Viburnum paid a premium for those despite the fact the market price of the securities fell well below the entitlement price.
There was a chance that UBI would not get FDA 510k approval hence Viburnum must have included the right to reprice the offer in the event trading of UBI CDI's fell below $0.10. Lesson learnt.
John clearly wanted to do a deal that was best for existing shareholders. Hence the entitlement offer and intention to raise capital announcement was made. UBI needs extra money to build inventory to then generate sales.
If you are an existing shareholder you have an opportunity to take up an entitlement offer at $0.15 per share & and attaching options exercisable at $0.20 it's a no brainer. Record Date is 4/4/24
People need to understand the entitlement offer that occurred in...
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $35.86M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.5¢ | $14.86K | 92.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10650 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 19606 | 1 |
View Market Depth
| Last trade - 15.09pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
16.0¢ |
Change
0.005 ( 10.3 %) |
||||
| Open | High | Low | Volume | ||
| 15.5¢ | 16.0¢ | 15.5¢ | 48789 | ||
| Last updated 10.33am 03/05/2024 ? | |||||
| UBI (ASX) Chart |